IN-VITRO UPTAKE OF BROMODEOXYURIDINE BY HUMAN NASOPHARYNGEAL CARCINOMA (NPC) AND ITS RELATION TO CLINICAL FINDINGS

Citation
Atc. Chan et al., IN-VITRO UPTAKE OF BROMODEOXYURIDINE BY HUMAN NASOPHARYNGEAL CARCINOMA (NPC) AND ITS RELATION TO CLINICAL FINDINGS, European journal of cancer. Part B, Oral oncology, 32B(1), 1996, pp. 50-54
Citations number
21
Categorie Soggetti
Oncology,"Dentistry,Oral Surgery & Medicine
ISSN journal
09641955
Volume
32B
Issue
1
Year of publication
1996
Pages
50 - 54
Database
ISI
SICI code
0964-1955(1996)32B:1<50:IUOBBH>2.0.ZU;2-A
Abstract
A cell kinetic study of 27 newly diagnosed patients with nasopharyngea l carcinoma (NPC) using the in vitro bromodeoxyuridine (BrdU) techniqu e was performed. The results were reproducible as demonstrated by thre e independent sections performed on each patient. No correlation betwe en BrdU labelling index (LI) and Ho's clinical staging was found. A hi gher LI was associated with the development of distant metastases (P = 0.057). Statistically significant correlation was found between low L I and longer duration required to achieve complete remission in the pr imary site of disease (P = 0.026). This study suggests a potential rol e for in vitro BrdU labelling index as a prognosticator for NPC prior to treatment.